Bionano Genomics, Inc. (NASDAQ:BNGO) Position Raised by Geode Capital Management LLC

Geode Capital Management LLC lifted its position in shares of Bionano Genomics, Inc. (NASDAQ:BNGO) by 47.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 882,854 shares of the company’s stock after acquiring an additional 283,639 shares during the period. Geode Capital Management LLC owned 1.03% of Bionano Genomics worth $401,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of BNGO. Carret Asset Management LLC grew its position in Bionano Genomics by 89.0% in the 3rd quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock worth $39,000 after purchasing an additional 40,055 shares during the last quarter. GSA Capital Partners LLP bought a new position in Bionano Genomics in the 3rd quarter worth approximately $46,000. Finally, Armistice Capital LLC bought a new position in Bionano Genomics in the 2nd quarter worth approximately $1,138,000. Institutional investors and hedge funds own 11.35% of the company’s stock.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH lowered Bionano Genomics from a “buy” rating to a “neutral” rating in a research report on Friday, November 15th.

Bionano Genomics Trading Down 0.3 %

Shares of NASDAQ:BNGO opened at $0.23 on Monday. The company has a 50 day moving average of $0.25 and a 200-day moving average of $0.40. The company has a current ratio of 1.43, a quick ratio of 0.99 and a debt-to-equity ratio of 0.07. The firm has a market cap of $26.49 million, a P/E ratio of -0.10 and a beta of 2.22. Bionano Genomics, Inc. has a twelve month low of $0.19 and a twelve month high of $1.55.

About Bionano Genomics

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.